VEGFA and neoplasm: Interesting recent pre-clinical data have highlighted the potential importance of measuring the concentration of circulating tumour cells, which depend critically on tumour circulation for intravasation, as potential biomarkers of VEGF inhibitors (Ebos et al, 2009; Paez-Ribes et al, 2009; Reynolds et al, 2009).